Hillrom and Welch Allyn are a part of Baxter.
Clindamycin Phosphate in 0.9% Sodium Chloride Injection, 300 mg/50 mL in GALAXY Plastic Container. Liquid Premix.
Item Number: 2G3455
GTIN:
00303389545507
GTIN-CS:
50303389545502
Added to Your Cart
Product Availability by Store Location
Hours
Clindamycin Phosphate in 0.9% Sodium Chloride Injection, 300 mg/50 mL in GALAXY Plastic Container. Liquid Premix. Please refer to full Prescribing Information, including Boxed Warning for Clostridioides difficile-associated diarrhea (CDAD) and Colitis. NDC 0338-9545-50.
Product Characteristics
| Trademark | GALAXY is a trademark of Baxter International Inc., and it's subsidiaries. |
| Volume | 50.0 ml |
| DEHP Free | Yes |
| PVC Free | Yes |
| Latex Free | Yes |
| Shelf Life from Manufacture | 18 months |
| Concentration | 6 mg/mL |
| Container Type | GALAXY |
| Containes Preservative | No |
| Diluent | Sodium Chloride |
| Dosage Form | Liquid |
| Polyethlene Lined | No |
| Rx Only | Yes |
| Storage Recommendations | It is recommended that GALAXY plastic containers be stored at 20°C to 25°C (68°F to 77°F) excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Avoid temperatures above 30°C. |
| Strength | 300 mg/50 mL |
Carton
| Units per Case | 24.0 |
| Carton Weight | 3.45 Pfund |
| Carton Length | 12.2 Zoll |
| Carton Width | 6.3 Zoll |
| Carton Height | 3.1 Zoll |
| Carton Volume | 238.27 ci |
Reimbursement Information
| HCPCS Code | HCPCS Description |
| A4216 | STERILE WATER, 0.9% Sodium Chloride AND/OR DEXTROSE DILUENT/FLUSH, 10 ML |
| J0737 | Injection, clindamycin phosphate, 300mg |
| Medication Delivery Reimbursement Hotline | 888-338-0001 |
Information Source : CMS
Disclaimer:The coverage, coding, and payment information included in this guide has been compiled from various resources for informational use as a tool to assist providers with reimbursement issues. This information is current as of 3/31/2008; however this information is subject to change and should not be construed as legal advice. Providers should exercise independent clinical judgment when selecting codes and submitting claims to accurately reflect services rendered to individual patients. Baxter Healthcare Corporation does not guarantee success in obtaining insurance payments. Providers are encouraged to contact third-party payors for specific information on their coverage, coding, and payment policies.
Disclaimer:The coverage, coding, and payment information included in this guide has been compiled from various resources for informational use as a tool to assist providers with reimbursement issues. This information is current as of 3/31/2008; however this information is subject to change and should not be construed as legal advice. Providers should exercise independent clinical judgment when selecting codes and submitting claims to accurately reflect services rendered to individual patients. Baxter Healthcare Corporation does not guarantee success in obtaining insurance payments. Providers are encouraged to contact third-party payors for specific information on their coverage, coding, and payment policies.
| Item Number | 2G3455 |
| Sales Unit | case |
| GTIN | 00303389545507 |
| GTIN-CS | 50303389545502 |
| National Drug Code | 0338954550 |
Documentation
203052r1
Do you want to save the changes before you leave?
We are processing your request, do not go back, refresh or close the window.
Please wait...
Please wait...



